Innlanz Limited

Equities

INL

AU0000199002

Other Specialty Retailers

Market Closed - Australian S.E. 01:04:25 22/04/2024 BST 5-day change 1st Jan Change
0.01 AUD -9.09% Intraday chart for Innlanz Limited -.--% -16.67%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Innlanz Limited Announces Resignation of Jhon Shen as Executive Director CI
Innlanz Limited Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Innlanz Limited Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Innlanz Limited Announces the Resignation of Tracey Cray as Director, Effective 31 July 2022 CI
Innlanz Limited Reports Earnings Results for the Half Year Ended December 31, 2021 CI
Mediland Pharm Limited Announces Change of Principal Place of Business and Registered Office Address CI
Mediland Pharm Limited Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Mediland Pharm Limited completed the acquisition of Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. CI
Mediland Pharm Limited Reports Consolidated Earnings Results for the Half Year Ended December 31, 2020 CI
Mediland Pharm : Board Proposes New Zealand Hotel Buy; Shares Fall 10% MT
Mediland Pharm Limited agreed to acquire Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. for AUD 2.5 million. CI
Mediland Pharm Limited Declares No Dividend for the Year of 2020 CI
Mediland Pharm Limited Announces Audited Consolidated Earnings Results for the Full Year Ended June 30, 2020 CI
Mediland Pharm Limited Reports Earnings Results for the Full Year Ended June 30, 2020 CI
Mediland Pharm Limited Enters into Contract with Intercontinental Hotels Group as Supplier of Mediland-Branded Hand Sanitiser CI
Mediland Pharm Limited Reports Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2019 CI
250,000,000 Ordinary Shares of Mediland Pharm Limited are subject to a Lock-Up Agreement Ending on 20-FEB-2020. CI
Mediland Pharm Limited acquired Enti Financial Pty Ltd for AUD 1 million. CI
Mediland Pharm Limited Approves the Election of Leo Cui as Director CI
Mediland Pharm Limited completed the acquisition of Ian’s Health Lounge business. CI
Mediland Pharm Limited Enters into a Binding Term Sheet with Careline Australia Pty Limited CI
Mediland Pharm Limited Reports Preliminary Audited Consolidated and Parent Earnings Results for the Year Ended June 30, 2019 CI
Mediland to Launch its Own Branded Products CI
Chart Innlanz Limited
More charts
Innlanz Limited is an Australia-based retailer of cosmetics, jewelry, health, well-being, and wool products, serving the inbound Chinese tourism market in Australia and New Zealand. The Company, through its subsidiary, Ixora Investment Pty Ltd, owns the Heartland Ambassador Hamilton Hotel in New Zealand. Its other subsidiaries include Mediland Pharm NZ Ltd and The Collection Hotels and Resorts Pty Ltd.
More about the company
  1. Stock Market
  2. Equities
  3. INL Stock
  4. News Innlanz Limited
  5. Mediland Pharm : Board Proposes New Zealand Hotel Buy; Shares Fall 10%